CELESTICA INC. (CLS): what the price requires
At today's price, CELESTICA INC. (CLS) is priced for today's economics sustained for ~30.3 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/CLS
Headline
| Field | Value |
|---|---|
| Ticker | CLS |
| Company | CELESTICA INC. |
| Current price | $344.45/sh |
| Composition | CCS (Connectivity & Cloud Solutions) 74% / ATS (Advanced Technology Solutions) 26% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | segment |
| Must persist for | 30.3y |
Solve inputs: computed at a 12.7% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~3.9 years.
Reconcile: at the x-ray's 9.3% required return this reads ~18.8 years; the models below use their own rates.
How unusual the bet is: high
| Reference | Value |
|---|---|
| cohort percentile (of 177 peers) | 100 |
| sustained it ~10 years at this level | 15% |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 3.12x | 4 | expensive |
| Earnings | 6.10x | 4 | expensive |
| Relative | 1.35x | 5 | expensive |
| Growth | 0.88x | 3 | justifies |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.1%); the inversion above states its own rate.
Per-Model Detail (n=16)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $257.84 | 1.34x | yes | FCF base $0.8B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.1%, 7yr projection |
| DCF Exit Multiple | Growth | $391.58 | 0.88x | yes | Exit EV/EBITDA: 26.7x / 29.7x / 32.7x (bear / base = today's held flat / bull), 7yr |
| Relative Valuation | Relative | $254.50 | 1.35x | yes | P/E 27.87x (blended: static sector reference 22x + trailing (TTM) 42x), scenarios: 22.3x / 27.9x / 33.4x (bear / base = reference held flat / bull), EV/EBITDA 20.1x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $89.57 | 3.85x | yes | BV/sh $18.13, ROE (TTM) 45.7%, ke 9.3% |
| Two-Stage Excess Return | Asset | $232.85 | 1.48x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $499.79 | 0.69x | yes | Rev $13.8B, growth 30% (input: historical growth; tapered), Terminal P/S: 2.3x / 2.9x / 3.5x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $99.00 | 3.48x | yes | EPS $8.25, growth 1% (input: historical EPS growth), PEG=29.68 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $16.83 | 20.47x | yes | Normalized EBIT (latest-period EBIT; under 3y history) $0.27B × (1−17%) / WACC 9.1% → EPV (no growth) (excluded from median) |
| Residual Income | Asset | $143.77 | 2.40x | yes | BV $18.13 + 5yr PV of (ROE (TTM) 45.7% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $58.02 | 5.94x | yes | √(22.5 × EPS $8.25 × BVPS $18.13) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $183.70 | 1.88x | yes | EBITDA $1.36B × sector EV/EBITDA 16.0x |
| FCF Yield | Earnings | $41.29 | 8.34x | yes | FCF $491.5M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $34.35 | 10.03x | yes | SBC-adj FCF $0.42B (FCF $0.49B − SBC $0.07B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $266.20 | 1.29x | yes | EPS $8.25 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $17.10 | 20.14x | yes | BV $18.13 × (ROIC 8.6% / WACC 9.1%) (excluded from median) |
| P/Sales Sector | Relative | $595.91 | 0.58x | yes | Revenue $13.79B × sector P/S 5.0x |
| PEG Fair Value | Relative | $309.38 | 1.11x | yes | EPS $8.25 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $89.19 | 3.86x | yes | EPS $8.25 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $394.4m |
| Net debt / NOPAT (after-tax) | 0.48x |
| Net debt / operating income (pre-tax) | 0.40x |
| Interest coverage | 17.8x |
| Burning cash | no |
Bullet Takeaways
- Celestica has remade itself from a low-margin contract manufacturer into the assembly arm of the AI-datacenter buildout, with its Connectivity & Cloud Solutions segment now roughly three-quarters of the business and growing about 76% year over year.
- The balance sheet is a quiet strength: trailing operating income covers interest more than twenty times over and net debt sits at roughly a third of a year's operating profit, so the growth is funded from a position of safety rather than stress.
- The watch item is customer concentration: CCS leans on a small number of hyperscaler clients, so the same demand that drove management to lift full-year 2026 revenue guidance to about $19 billion is the demand whose timing the company does not control.
Bull Case
Begin with the balance sheet, because it is what lets Celestica run hard without flinching. Trailing operating income of roughly $1.2 billion covers interest more than twenty times over, net debt sits at about a third of a single year's operating profit, and the company throws off real free cash flow, around $490 million on a trailing basis, while it scales. That is not the financial posture of a fragile manufacturer chasing a boom. It is a company that can fund roughly a billion dollars of planned capital spending and still target positive free cash flow in the same year, which is exactly the position from which management chose to lift its full-year 2026 revenue outlook toward $19 billion. A safe balance sheet is what turns a demand surge into compounding rather than into a stretch.
The business underneath has genuinely changed shape. Celestica is no longer the commodity electronics-manufacturing-services name it once was; the Connectivity & Cloud Solutions segment, now about 74% of revenue, is the part that builds the networking and compute hardware hyperscalers deploy for AI, and it grew roughly 76% year over year in the first quarter. The mix shift toward higher-value hardware platform work is lifting operating margins to records. The demand backdrop is corroborated across the cohort: Vertiv, a peer in the same AI-infrastructure supply chain, tells its own investors it is "increasing capacity to support additional demand for AI infrastructure", and Amphenol attributes its growth to "strong organic growth in the Communications Solutions segment". The same wave lifts Celestica, and its return on equity, north of 45% on trailing results, shows the operating leverage is real.
What the bull is really buying is durable participation in a multi-year infrastructure cycle at a company that has earned the right to grow. The price reflects this: of all the valuation methods, only the growth-dependent ones reach today's level, which is the market's way of saying it is paying for compounding the static frames structurally cannot price. If hyperscaler AI capital spending sustains, Celestica is positioned as one of the contract builders the spending flows through, with the margin trajectory and the cash generation to convert that flow into shareholder value. The reframe is simple: this stopped being a margin-thin assembler and became infrastructure plumbing for AI, priced accordingly.
Bear Case
The single external variable with the most leverage on this thesis is hyperscaler capital spending, and Celestica controls none of it. The Connectivity & Cloud Solutions segment that drives the growth depends on a small number of very large cloud customers, and that concentration is the structural fragility. When roughly 80% of incremental revenue growth comes from one segment serving a handful of clients, a single customer's decision to slow deployments, dual-source, or pull a build-out forward and then digest it can swing a quarter hard. The same dynamic that let management raise full-year revenue guidance by $2 billion in one step can run in reverse, because demand that arrives in a rush from a few buyers is demand that can pause the same way.
The valuation makes that fragility expensive to be wrong about. At today's price the asset-value methods, the earnings-power methods, and the peer-multiple methods all land well below the price; only the growth-dependent frames reach it, and they get there by assuming the recent pace persists for years. Worked backward, the price embeds operating growth held near its self-funding ceiling for roughly three decades, a persistence that history has rewarded only about 15% of fast-growers with even ten years. The earnings-power lens is the sharpest illustration: capitalized at a no-growth perpetuity, the price sits many times above what current earnings alone justify. The price is not paying for what Celestica earns; it is paying for what it must keep earning at an accelerating clip.
There is also a quieter caution in how the company talks about its own profits. Celestica leads its results with adjusted, non-GAAP figures, and the gap between those and reported GAAP earnings, where trailing GAAP EPS runs around $8.25, is the kind of distance a careful reader should hold in mind when the headline numbers look heroic. The balance sheet is genuinely sound, so this is not a solvency bear; net debt at roughly a third of operating profit and interest covered more than twenty times mean the downside is not bankruptcy. The downside is multiple compression. If AI infrastructure spending normalizes from its current pace, the static methods that already say richly valued become the gravity the price falls back toward, and a cyclical hardware supplier does not hold a growth multiple through a cyclical pause.
Valuation
Lead with what the price is betting, because working the price backward states it cleanly. At today's level the market is paying for the Advanced Technology Solutions segment, the part carrying the priced-in premium, to grow at close to its self-funding ceiling for roughly three decades. Of the fast-growers history can measure, only about 15% sustained that kind of pace even ten years. That is the assumption embedded in the price, and the rest of the valuation is a question of how far past the demonstrated economics that assumption sits.
The answer from the method disagreement is: far, on every frame except growth. The asset-value methods, reading Celestica off its roughly $18 of book value per share and even a strong return on it, land well under the price. The earnings-power methods land far below, with the no-growth earnings frame sitting many multiples beneath today's level. The peer-multiple methods land closer but still below, placing the stock above where its cohort's blended earnings and EV-to-EBITDA multiples reach. Only the growth-dependent discounted cash-flow and future-market-cap methods reach the price, and they do so by crediting roughly 30% revenue growth tapering over a multi-year horizon. When three of the four method families say richly valued and only the growth family reaches the price, the price is a durability premium: the market is paying for compounding the static lenses cannot frame, and that is a description of the bet, not a verdict that it is wrong.
Solvency turns the read from a binary into a question of degree. Net debt sits at roughly a third of a year's operating profit, interest is covered more than twenty times over, and the company generates free cash flow while it invests, so the downside here is not insolvency. It is the distance between a growth multiple and the static-method floor. Set against the cohort, the comparison that sharpens the picture is the AI-infrastructure supply chain itself: Vertiv is expanding capacity for the same demand wave, and Amphenol is riding the same communications growth, which tells you Celestica's premium is the cycle's premium. The honest close is that the balance sheet bounds the downside and the growth assumption defines the upside; the price has already chosen to believe the assumption.
Catalysts
The dominant catalyst is the guidance raise, which the first quarter forced. Revenue grew about 53% year over year to roughly $4.05 billion, the Connectivity & Cloud Solutions segment accelerated to about 76% growth, and management responded by lifting full-year 2026 revenue guidance to approximately $19 billion from $17 billion and raising its adjusted operating margin target. A two-billion-dollar single-step increase to an annual outlook is the kind of revision that resets expectations, and the next print will test whether the momentum behind it holds or whether the raise pulled the optimism forward.
The structural catalyst is the mix shift toward higher-value work. Celestica's move into Hardware Platform Solutions, the higher-margin end of its CCS portfolio, is what is lifting operating margins toward records while revenue scales, and continued progress there is what would justify the premium the price already carries. The company plans roughly $1 billion of capital spending in 2026 while still targeting positive free cash flow, so the watch item is whether that investment converts into the capacity hyperscalers are actually buying.
Analyst sentiment has chased the fundamentals upward. Recent targets span a wide range, with TD Cowen raising its target to $430 in April 2026 and Rothschild and Co initiating at $460, while the broader consensus sits lower, which is the tension to watch: the stock is priced near the upper end of where even bullish analysts place it. The risk that would move the story is the one the company itself flags, customer concentration in the segment driving the growth, so any signal of a hyperscaler digestion period would matter more here than at a more diversified supplier.
Peer Cohorts (Per Segment, With Filing Citations)
CCS (Connectivity & Cloud Solutions) / ATS (Advanced Technology Solutions) (reported)
- SANM (Sanmina Corporation)
- (no filing in the citation store)
- JBL (JABIL INC)
- (no filing in the citation store)
- PLXS (PLEXUS CORP.)
- (no filing in the citation store)
- FLEX (FLEX LTD.)
- (no filing in the citation store)
- BHE (BENCHMARK ELECTRONICS, INC.)
- (no filing in the citation store)
- TTMI (TTM TECHNOLOGIES INC)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Q1 2026 earnings release · Q1 2026 guidance update · Q1 2026 earnings release and guidance update · analyst notes, 2026